You may also like
Is Platelet Function as Measured by Thrombelastograph Monitoring in Whole Blood Affected by Platelet Inhibitors?
Platelet inhibitors, especially the glycoprotein (GP) IIb/IIIa receptor antagonists, have demonstrated their effectiveness in reducing the acute ischemic complications of percutaneous coronary intervention (PCI) and in improving clinical outcomes in patients with acute coronary crisis.
Treating Heart Failure With Enhanced External Counterpulsation (EECP): Design of the Prospective Evaluation of EECP in Heart Failure (PEECH) Trial
Enhanced external counterpulsation (EECP) treatment can improve exercise tolerance in patients with ischemic heart disease; however, the possible benefits of EECP in patients with stable heart failure (HF) and left ventricular dysfunction (LVD) are unclear.
Dextran Sulfate as a Leukocyte–Endothelium Adhesion Molecule Inhibitor of Lung Injury in Pediatric Open-Heart Surgery
To prevent this injury, we used a leukocyte–endothelial cell adhesion molecule blocking agent, dextran sulfate, in a clinical setting.